FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945585943> ?p ?o ?g. }

• W2945585943 endingPage "179" @default.
• W2945585943 startingPage "175" @default.
• W2945585943 abstract "Immune checkpoint inhibitors (ICI) significantly improve overall survival (OS) in patients with advanced melanoma, but immune-related colitis may occur and warrant anti-tumor necrosis factor α (TNFα) treatment in severe forms. A nationwide, multicenter retrospective survey was conducted to assess both, the real-life incidence of grade 3/4 ICI-induced colitis treated with anti-TNFα, in patients with advanced melanoma, and the consequence of this therapeutic strategy on disease outcome. All patients with advanced melanoma treated with anti-TNFα agents for severe ICI-related colitis in the participating centers were included. Relative incidence was calculated according to the total number of patients treated with ICI in network centers during the period of inclusion. The possible impact of anti-TNFα treatment on disease outcome was evaluated through comparison of objective response rate, progression-free survival, and OS with pivotal literature data. Twenty-seven patients from 13 tertiary referral centers were included. Overall, severe ICI-related colitis treated with anti-TNFα occurred in 1% of patients with advanced melanoma, mostly with ipilimumab. Infliximab was successfully used in all patients but 1, mostly after 1 infusion. OS and progression-free survival of 12 and 3 months, respectively, were observed in these patients, along with an objective response rate of 41% at 12 months. This survey shows a low real-life incidence of severe colitis requiring anti-TNFα. Response rates to immunotherapy and survival data do not appear to significantly differ from those observed in pivotal studies. Severe ICI-induced colitis requiring anti-TNFα treatment appears to be a rare event in advanced melanoma, and infliximab does not seem to adversely affect disease outcome." @default.
• W2945585943 created "2019-05-29" @default.
• W2945585943 creator A5002307250 @default.
• W2945585943 creator A5002644565 @default.
• W2945585943 creator A5009289403 @default.
• W2945585943 creator A5010934547 @default.
• W2945585943 creator A5014376121 @default.
• W2945585943 creator A5019418749 @default.
• W2945585943 creator A5026504570 @default.
• W2945585943 creator A5037838523 @default.
• W2945585943 creator A5041302754 @default.
• W2945585943 creator A5044024585 @default.
• W2945585943 creator A5044284945 @default.
• W2945585943 creator A5052180979 @default.
• W2945585943 creator A5055280857 @default.
• W2945585943 creator A5064052929 @default.
• W2945585943 creator A5071092697 @default.
• W2945585943 creator A5090160947 @default.
• W2945585943 date "2019-06-01" @default.
• W2945585943 modified "2023-09-27" @default.
• W2945585943 title "Incidence and Clinical Impact of Anti-TNFα Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit Survey" @default.
• W2945585943 cites W1516437155 @default.
• W2945585943 cites W1526068104 @default.
• W2945585943 cites W1809627231 @default.
• W2945585943 cites W1832467332 @default.
• W2945585943 cites W2097995306 @default.
• W2945585943 cites W2105057287 @default.
• W2945585943 cites W2112121482 @default.
• W2945585943 cites W2112772954 @default.
• W2945585943 cites W2123363005 @default.
• W2945585943 cites W2128035403 @default.
• W2945585943 cites W2128758225 @default.
• W2945585943 cites W2152897456 @default.
• W2945585943 cites W2166662937 @default.
• W2945585943 cites W2185117068 @default.
• W2945585943 cites W2289841322 @default.
• W2945585943 cites W2314922821 @default.
• W2945585943 cites W2316668818 @default.
• W2945585943 cites W2346424903 @default.
• W2945585943 cites W2346672202 @default.
• W2945585943 cites W2431658434 @default.
• W2945585943 cites W2549481046 @default.
• W2945585943 cites W2610766845 @default.
• W2945585943 cites W2737074543 @default.
• W2945585943 cites W2753432434 @default.
• W2945585943 cites W2760893760 @default.
• W2945585943 cites W2765314233 @default.
• W2945585943 cites W2779658193 @default.
• W2945585943 cites W2782898385 @default.
• W2945585943 cites W2805482047 @default.
• W2945585943 cites W2897516580 @default.
• W2945585943 doi "https://doi.org/10.1097/cji.0000000000000268" @default.
• W2945585943 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31090656" @default.
• W2945585943 hasPublicationYear "2019" @default.
• W2945585943 type Work @default.
• W2945585943 sameAs 2945585943 @default.
• W2945585943 citedByCount "51" @default.
• W2945585943 countsByYear W29455859432019 @default.
• W2945585943 countsByYear W29455859432020 @default.
• W2945585943 countsByYear W29455859432021 @default.
• W2945585943 countsByYear W29455859432022 @default.
• W2945585943 countsByYear W29455859432023 @default.
• W2945585943 crossrefType "journal-article" @default.
• W2945585943 hasAuthorship W2945585943A5002307250 @default.
• W2945585943 hasAuthorship W2945585943A5002644565 @default.
• W2945585943 hasAuthorship W2945585943A5009289403 @default.
• W2945585943 hasAuthorship W2945585943A5010934547 @default.
• W2945585943 hasAuthorship W2945585943A5014376121 @default.
• W2945585943 hasAuthorship W2945585943A5019418749 @default.
• W2945585943 hasAuthorship W2945585943A5026504570 @default.
• W2945585943 hasAuthorship W2945585943A5037838523 @default.
• W2945585943 hasAuthorship W2945585943A5041302754 @default.
• W2945585943 hasAuthorship W2945585943A5044024585 @default.
• W2945585943 hasAuthorship W2945585943A5044284945 @default.
• W2945585943 hasAuthorship W2945585943A5052180979 @default.
• W2945585943 hasAuthorship W2945585943A5055280857 @default.
• W2945585943 hasAuthorship W2945585943A5064052929 @default.
• W2945585943 hasAuthorship W2945585943A5071092697 @default.
• W2945585943 hasAuthorship W2945585943A5090160947 @default.
• W2945585943 hasConcept C120665830 @default.
• W2945585943 hasConcept C121332964 @default.
• W2945585943 hasConcept C121608353 @default.
• W2945585943 hasConcept C126322002 @default.
• W2945585943 hasConcept C143998085 @default.
• W2945585943 hasConcept C17991360 @default.
• W2945585943 hasConcept C203014093 @default.
• W2945585943 hasConcept C2775862500 @default.
• W2945585943 hasConcept C2777138892 @default.
• W2945585943 hasConcept C2777658100 @default.
• W2945585943 hasConcept C2777701055 @default.
• W2945585943 hasConcept C2778260677 @default.
• W2945585943 hasConcept C2779134260 @default.
• W2945585943 hasConcept C2780479503 @default.
• W2945585943 hasConcept C2781433595 @default.
• W2945585943 hasConcept C502942594 @default.
• W2945585943 hasConcept C61511704 @default.
• W2945585943 hasConcept C71924100 @default.
• W2945585943 hasConcept C90924648 @default.

• next